Abstract
AbstractDevelopment of simple, robust, and noninvasive therapeutic approaches to treat cancers and improve survival rates is a grand challenge in clinical biomedicine. In particular, the sizes and shape of the nanomaterials play a vital role in dictating their biodistribution and clearance pathways. It remains elusive how the size and shape of a nanomaterial affect its therapeutic efficacy in cancer diagnosis and treatments. To tackle the above problem, the effects of size and shape of Cu2(OH)PO4 nanostructures (nanosheets and quantum dots) on the photodynamic therapy (PDT) in destroying malignant drug‐resistant lung tumors and on combating the tumor hypoxia problem are investigated and compared. The photocatalytic mechanism of Cu2(OH)PO4 nanostructures mainly involves the generation of reactive oxygen species (ROS), such as hydroxyl radical (·OH) and singlet oxygen (1O2). Under an oxygen deprivation condition, Cu2(OH)PO4 nanosheets still can generate OH radicals to kill cancer cells upon near‐infrared (NIR) light irradiation. Overall, in vitro and in vivo experiments show that Cu2(OH)PO4 nanosheets can overcome tumor hypoxia problems and effectively mediate dual modal PDT and photothermal therapeutic (PTT) effects on destruction of NCI‐H23 lung tumors in mice using ultralow doses (350 mW cm−2) of NIR (915 nm) light.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
